{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:17:19Z","timestamp":1783455439749,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK135933"],"award-info":[{"award-number":["DK135933"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012729","name":"Case Western Reserve University School of Medicine | Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University","doi-asserted-by":"publisher","award":["RES516810"],"award-info":[{"award-number":["RES516810"]}],"id":[{"id":"10.13039\/100012729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012324","name":"University Hospitals","doi-asserted-by":"publisher","award":["100.83311"],"award-info":[{"award-number":["100.83311"]}],"id":[{"id":"10.13039\/100012324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["DK068306"],"award-info":[{"award-number":["DK068306"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cystine stones are caused by pathogenic variants in\n                    <jats:italic>SLC3A1<\/jats:italic>\n                    or\n                    <jats:italic>SLC7A9<\/jats:italic>\n                    . Our prior study revealed a large gap between genetic and clinical prevalence. With increasing discovery of novel variants, we aim to assess how these impact genetic prevalence estimates. Due to the disease rarity, direct patient recruitment and observation is impractical. We applied a population genetics approach to estimate genetic burden and prevalence. Pathogenic variants were identified from the 2022 Human Gene Mutation Database and intersected with population variants from the 1000 Genomes Project Phase 3. Allele frequency, carrier rate, and affected rate were calculated. Results were compared to prior data, and simulations were performed across varying initial allele frequencies. We identified 116 and 76 novel pathogenic variants in\n                    <jats:italic>SLC3A1<\/jats:italic>\n                    and\n                    <jats:italic>SLC7A9<\/jats:italic>\n                    , respectively. Pathogenic allele frequencies increased by +0.12% (\n                    <jats:italic>SLC3A1<\/jats:italic>\n                    ) and 0.16% (\n                    <jats:italic>SLC7A9<\/jats:italic>\n                    ), leading to fold-changes in genetic prevalence of 1.51x and 2.78x. The combined updated prevalence is 1 in 17,612, a 1.74x increase. Simulations confirmed the fold-change magnitude. In rare diseases, even modest discovery of new variants can significantly increase genetic prevalence. As shown in cystine stone, this helps narrow\u2014but not close\u2014the gap with clinical prevalence. Further efforts are needed to bridge this gap and guide treatment development.\n                  <\/jats:p>","DOI":"10.1038\/s41431-026-02085-y","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:58:35Z","timestamp":1775725115000},"page":"956-963","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["How variant discovery redefines genetic prevalence: the case of cystine stone disease"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4827-9920","authenticated-orcid":false,"given":"Chen-Han Wilfred","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0358-9581","authenticated-orcid":false,"given":"Katreya","family":"Lovrenert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Bodner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7130-0030","authenticated-orcid":false,"given":"Friedhelm","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3073-7463","authenticated-orcid":false,"given":"Fredrick R.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"2085_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S0959-437X(00)00198-2","volume":"11","author":"M Palac\u0131\u0301n","year":"2001","unstructured":"Palac\u0131\u0301n M, Borsani G, Sebastio G. The molecular bases of cystinuria and lysinuric protein intolerance. Curr Opin Genet Dev. 2001;11:328\u201335. https:\/\/doi.org\/10.1016\/S0959-437X(00)00198-2.","journal-title":"Curr Opin Genet Dev"},{"key":"2085_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/ijms21010119","volume":"21","author":"R Yahyaoui","year":"2019","unstructured":"Yahyaoui R, P\u00e9rez-Fr\u00edas J. Amino acid transport defects in human inherited metabolic disorders. Int J Mol Sci. 2019;21:119. https:\/\/doi.org\/10.3390\/ijms21010119.","journal-title":"Int J Mol Sci"},{"key":"2085_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/s0025-6196(12)60043-3","volume":"68","author":"DS Milliner","year":"1993","unstructured":"Milliner DS, Murphy ME. Urolithiasis in pediatric patients. Mayo Clin Proc. 1993;68:241\u20138. https:\/\/doi.org\/10.1016\/s0025-6196(12)60043-3.","journal-title":"Mayo Clin Proc"},{"key":"2085_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00467-004-1663-1","volume":"20","author":"T Knoll","year":"2005","unstructured":"Knoll T, Z\u00f6llner A, Wendt-Nordahl G, Michel MS, Alken P. Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol. 2005;20:19\u201324. https:\/\/doi.org\/10.1007\/s00467-004-1663-1.","journal-title":"Pediatr Nephrol"},{"key":"2085_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.kint.2020.06.035","volume":"99","author":"A Servais","year":"2021","unstructured":"Servais A, Thomas K, Dello Strologo L, Sayer JA, Bekri S, Bertholet-Thomas A, et al. Cystinuria: clinical practice recommendation. Kidney Int. 2021;99:48\u201358. https:\/\/doi.org\/10.1016\/j.kint.2020.06.035.","journal-title":"Kidney Int"},{"key":"2085_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.juro.2017.09.034","volume":"199","author":"JI Friedlander","year":"2018","unstructured":"Friedlander JI, Antonelli JA, Canvasser NE, Morgan MSC, Mollengarden D, Best S, et al. Do urinary cystine parameters predict clinical stone activity? J Urol. 2018;199:495\u20139. https:\/\/doi.org\/10.1016\/j.juro.2017.09.034.","journal-title":"J Urol"},{"key":"2085_CR7","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00467-023-06242-z","volume":"39","author":"CHW Wu","year":"2024","unstructured":"Wu CHW, Badreddine J, Su E, Tay K, Lin HTC, Rhodes S, et al. Beyond the kidney: extra-renal manifestations of monogenic nephrolithiasis and their significance. Pediatr Nephrol. 2024;39:1429\u201334. https:\/\/doi.org\/10.1007\/s00467-023-06242-z.","journal-title":"Pediatr Nephrol"},{"key":"2085_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-19","volume":"7","author":"T Eggermann","year":"2012","unstructured":"Eggermann T, Venghaus A, Zerres K. Cystinuria: an inborn cause of urolithiasis. Orphanet J Rare Dis. 2012;7:19. https:\/\/doi.org\/10.1186\/1750-1172-7-19.","journal-title":"Orphanet J Rare Dis"},{"key":"2085_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/ng0494-415","volume":"6","author":"E Pras","year":"1994","unstructured":"Pras E, Arber N, Aksentijevich I, Katz G, Schapiro JM, Prosen L, et al. Localization of a gene causing cystinuria to chromosome 2p. Nat Genet. 1994;6:4. https:\/\/doi.org\/10.1038\/ng0494-415.","journal-title":"Nat Genet"},{"key":"2085_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/12652","volume":"23","author":"L Feliubadal\u00f3","year":"1999","unstructured":"Feliubadal\u00f3 L, Font M, Purroy J, Rousaud F, Estivill X, Nunes V, et al. Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT. Nat Genet. 1999;23:52\u20137. https:\/\/doi.org\/10.1038\/12652.","journal-title":"Nat Genet"},{"key":"2085_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/gte.2007.0113","volume":"12","author":"M Di Perna","year":"2008","unstructured":"Di Perna M, Louizou E, Fischetti L, Dedoussis GVZ, Stanziale P, Michelakakis H, et al. Twenty-four novel mutations identified in a cohort of 85 patients by direct sequencing of the SLC3A1 and SLC7A9 cystinuria genes. Genet Test. 2008;12:351\u20135. https:\/\/doi.org\/10.1089\/gte.2007.0113.","journal-title":"Genet Test"},{"key":"2085_CR12","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/ng0494-420","volume":"6","author":"MJ Calonge","year":"1994","unstructured":"Calonge MJ, Gasparini P, Chillar\u00f3n J, Chill\u00f3n M, Gallucci M, Rousaud F, et al. Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nat Genet. 1994;6:420\u20135. https:\/\/doi.org\/10.1038\/ng0494-420.","journal-title":"Nat Genet"},{"key":"2085_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00240-023-01473-z","volume":"51","author":"CHW Wu","year":"2023","unstructured":"Wu CHW, Badreddine J, Chang J, Huang YRM, Kim FJ, Wild T, et al. Population genetics analysis of SLC3A1 and SLC7A9 revealed the etiology of cystine stone may be more than what our current genetic knowledge can explain. Urolithiasis. 2023;51:101. https:\/\/doi.org\/10.1007\/s00240-023-01473-z.","journal-title":"Urolithiasis"},{"key":"2085_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00439-020-02135-5","volume":"139","author":"MN Bainbridge","year":"2020","unstructured":"Bainbridge MN. Determining the incidence of rare diseases. Hum Genet. 2020;139:569\u201374. https:\/\/doi.org\/10.1007\/s00439-020-02135-5.","journal-title":"Hum Genet"},{"key":"2085_CR15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00439-015-1551-8","volume":"134","author":"SJ Schrodi","year":"2015","unstructured":"Schrodi SJ, DeBarber A, He M, Ye Z, Peissig P, Van Wormer JJ, et al. Prevalence estimation for monogenic autosomal recessive diseases using population-based genetic data. Hum Genet. 2015;134:659\u201369. https:\/\/doi.org\/10.1007\/s00439-015-1551-8.","journal-title":"Hum Genet"},{"key":"2085_CR16","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.jaci.2013.11.038","volume":"133","author":"K Chen","year":"2014","unstructured":"Chen K, Wu W, Mathew D, Zhang Y, Browne SK, Rosen LB, et al. Autoimmunity due to RAG deficiency and estimated disease incidence in RAG1\/2 mutations. J Allergy Clin Immunol. 2014;133:880\u2013882.e10. https:\/\/doi.org\/10.1016\/j.jaci.2013.11.038.","journal-title":"J Allergy Clin Immunol"},{"key":"2085_CR17","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1681\/ASN.2014070698","volume":"26","author":"K Hopp","year":"2015","unstructured":"Hopp K, Cogal AG, Bergstralh EJ, Seide BM, Olson JB, Meek AM, et al. Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria. J Am Soc Nephrol. 2015;26:2559\u201370. https:\/\/doi.org\/10.1681\/ASN.2014070698.","journal-title":"J Am Soc Nephrol"},{"key":"2085_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101281","volume":"27","author":"CH Wilfred Wu","year":"2025","unstructured":"Wilfred Wu CH, Patel I, Lovrenert K, Eisner B, Meeks N, Chun-Hui Tsai A, et al. The role of double heterozygotes of SLC3A1 and SLC7A9 in the prevalence of cystine stones. Genet Med. 2025;27:101281. https:\/\/doi.org\/10.1016\/j.gim.2024.101281.","journal-title":"Genet Med"},{"key":"2085_CR19","doi-asserted-by":"publisher","first-page":"7571","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton A, Abecasis GR, Altshuler DM, Durbin RM, Abecasis GR, Bentley DR, et al. A global reference for human genetic variation. Nature. 2015;526:7571. https:\/\/doi.org\/10.1038\/nature15393.","journal-title":"Nature"},{"key":"2085_CR20","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/humu.24309","volume":"43","author":"S Gudmundsson","year":"2022","unstructured":"Gudmundsson S, Singer-Berk M, Watts NA, Phu W, Goodrich JK, Solomonson M, et al. Variant interpretation using population databases: lessons from gnomAD. Hum Mutat. 2022;43:1012\u201330. https:\/\/doi.org\/10.1002\/humu.24309.","journal-title":"Hum Mutat"},{"key":"2085_CR21","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1101\/gr.277908.123","volume":"33","author":"EG Atkinson","year":"2023","unstructured":"Atkinson EG, Artomov M, Loboda AA, Rehm HL, MacArthur DG, Karczewski KJ, et al. Discordant calls across genotype discovery approaches elucidate variants with systematic errors. Genome Res. 2023;33:999\u20131005. https:\/\/doi.org\/10.1101\/gr.277908.123.","journal-title":"Genome Res"},{"key":"2085_CR22","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Current clinical use of polygenic scores will risk exacerbating health disparities. Nat Genet. 2019;51:584\u201391. https:\/\/doi.org\/10.1038\/s41588-019-0379-x.","journal-title":"Nat Genet"},{"key":"2085_CR23","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","volume":"139","author":"PD Stenson","year":"2020","unstructured":"Stenson PD, Mort M, Ball EV, Chapman M, Evans K, Azevedo L, et al. The human gene mutation database (HGMD\u00ae): optimizing its use in a clinical diagnostic or research setting. Hum Genet. 2020;139:1197\u2013207. https:\/\/doi.org\/10.1007\/s00439-020-02199-3.","journal-title":"Hum Genet"},{"key":"2085_CR24","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1101\/gr.279273.124","volume":"34","author":"JA Gustafson","year":"2024","unstructured":"Gustafson JA, Gibson SB, Damaraju N, Zalusky MPG, Hoekzema K, Twesigomwe D, et al. High-coverage nanopore sequencing of samples from the 1000 Genomes Project to build a comprehensive catalog of human genetic variation. Genome Res. 2024;34:2061\u201373. https:\/\/doi.org\/10.1101\/gr.279273.124.","journal-title":"Genome Res"},{"key":"2085_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1126\/science.28.706.49","volume":"28","author":"GH Hardy","year":"1908","unstructured":"Hardy GH. Mendelian proportions in a mixed population. Science. 1908;28:49\u201350. https:\/\/doi.org\/10.1126\/science.28.706.49.","journal-title":"Science"},{"key":"2085_CR26","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.21037\/jtd.2017.09.14","volume":"9","author":"A Hazra","year":"2017","unstructured":"Hazra A. Using the confidence interval confidently. J Thorac Dis. 2017;9:4125\u201330. https:\/\/doi.org\/10.21037\/jtd.2017.09.14.","journal-title":"J Thorac Dis"},{"key":"2085_CR27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/1475-6773.12122","volume":"49","author":"BE Dowd","year":"2014","unstructured":"Dowd BE, Greene WH, Norton EC. Computation of standard errors. Health Serv Res. 2014;49:731\u201350. https:\/\/doi.org\/10.1111\/1475-6773.12122.","journal-title":"Health Serv Res"},{"key":"2085_CR28","unstructured":"R: The R Project for Statistical Computing [Internet]. [cited 2024 May 19]. Available from: https:\/\/www.r-project.org\/"},{"key":"2085_CR29","doi-asserted-by":"publisher","unstructured":"Wickham H ggplot2: Elegant Graphics for Data Analysis [Internet]. New York, NY: Springer; 2016 [cited 2024 May 10]. Available from: https:\/\/link.springer.com\/10.1007\/978-0-387-98141-3. https:\/\/doi.org\/10.1007\/978-0-387-98141-3","DOI":"10.1007\/978-0-387-98141-3"},{"key":"2085_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/jmg-2023-109488","volume":"61","author":"N Walsh","year":"2024","unstructured":"Walsh N, Cooper A, Dockery A, O\u2019Byrne JJ. Variant reclassification and clinical implications. J Med Genet. 2024;61:207\u201311. https:\/\/doi.org\/10.1136\/jmg-2023-109488.","journal-title":"J Med Genet"},{"key":"2085_CR31","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/gim.2015.166","volume":"18","author":"LR Susswein","year":"2016","unstructured":"Susswein LR, Marshall ML, Nusbaum R, Vogel Postula KJ, Weissman SM, Yackowski L, et al. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Med. 2016;18:823\u201332. https:\/\/doi.org\/10.1038\/gim.2015.166.","journal-title":"Genet Med"},{"key":"2085_CR32","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/j.1523-1755.2002.kid552.x","volume":"62","author":"E Botzenhart","year":"2002","unstructured":"Botzenhart E, Vester U, Schmidt C, Hesse A, Halber M, Wagner C, et al. Cystinuria in children: distribution and frequencies of mutations in the SLC3A1 and SLC7A9 genes. Kidney Int. 2002;62:1136\u201342. https:\/\/doi.org\/10.1111\/j.1523-1755.2002.kid552.x.","journal-title":"Kidney Int"},{"key":"2085_CR33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/jmg.2004.022244","volume":"42","author":"M Font-Llitjos","year":"2005","unstructured":"Font-Llitjos M, Jimenez-Vidal M, Bisceglia L, Di P, de Sanctis L, Rousaud F, et al. New insights into cystinuria: 40 new mutations, genotype\u2013phenotype correlation, and digenic inheritance causing partial phenotype. J Med Genet. 2005;42:58\u201368. https:\/\/doi.org\/10.1136\/jmg.2004.022244.","journal-title":"J Med Genet"},{"key":"2085_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/bju.12894","volume":"116","author":"KA Wong","year":"2015","unstructured":"Wong KA, Mein R, Wass M, Flinter F, Pardy C, Bultitude M, et al. The genetic diversity of cystinuria in a UK population of patients. BJU Int. 2015;116:109\u201316. https:\/\/doi.org\/10.1111\/bju.12894.","journal-title":"BJU Int"},{"key":"2085_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/mgg3.294","volume":"5","author":"P Gaildrat","year":"2017","unstructured":"Gaildrat P, Lebbah S, Tebani A, Sudri\u00e9-Arnaud B, Tostivint I, Bollee G, et al. Clinical and molecular characterization of cystinuria in a French cohort: relevance of assessing large-scale rearrangements and splicing variants. Mol Genet Genom Med. 2017;5:373. https:\/\/doi.org\/10.1002\/mgg3.294.","journal-title":"Mol Genet Genom Med"},{"key":"2085_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-1935-5","volume":"21","author":"SL Amarasinghe","year":"2020","unstructured":"Amarasinghe SL, Su S, Dong X, Zappia L, Ritchie ME, Gouil Q. Opportunities and challenges in long-read sequencing data analysis. Genome Biol. 2020;21:30. https:\/\/doi.org\/10.1186\/s13059-020-1935-5.","journal-title":"Genome Biol"},{"key":"2085_CR37","doi-asserted-by":"publisher","unstructured":"Wu CHW, Huang YRM, Ziadeh H, Jong BE, Dalal P, Lin HTC, et al. Genetic insights into nephrolithiasis and renal cancer predisposition: precision medicine in genes, diagnosis, and therapy. Seminars in Nephrology. 2025;151655. https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151655","DOI":"10.1016\/j.semnephrol.2025.151655"},{"key":"2085_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-023-01767-6","volume":"16","author":"D Liu","year":"2023","unstructured":"Liu D, Zhao Y, Xue X, Hou X, Xu H, Zhao X, et al. Novel compound heterozygous pathogenic variants in the SLC3A1 gene in a Chinese family with cystinuria. BMC Med Genomics. 2023;16:333. https:\/\/doi.org\/10.1186\/s12920-023-01767-6.","journal-title":"BMC Med Genomics"},{"key":"2085_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-017-3913-1","volume":"18","author":"HJ Martell","year":"2017","unstructured":"Martell HJ, Wong KA, Martin JF, Kassam Z, Thomas K, Wass MN. Associating mutations causing cystinuria with disease severity with the aim of providing precision medicine. BMC Genomics. 2017;18:550. https:\/\/doi.org\/10.1186\/s12864-017-3913-1.","journal-title":"BMC Genomics"},{"key":"2085_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.569389","volume":"8","author":"M Alghamdi","year":"2020","unstructured":"Alghamdi M, Alhasan KA, Taha Elawad A, Salim S, Abdelhakim M, Nashabat M, et al. Diversity of phenotype and genetic etiology of 23 cystinuria saudi patients: a retrospective study. Front Pediatr. 2020;8:569389. https:\/\/doi.org\/10.3389\/fped.2020.569389.","journal-title":"Front Pediatr"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02085-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02085-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02085-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:42:26Z","timestamp":1783413746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02085-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2085"],"URL":"https:\/\/doi.org\/10.1038\/s41431-026-02085-y","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Chen-Han Wilfred Wu is a member of the Executive Committee for the Harrington Scholar-Innovator Award Program, and conducts clinical trials with Moderna, Inc. Donald Bodner owns Fortec Litho LLC stock. Friedhelm Hildebrandt has a UofM patent, a patent pending of NPHP4, Brigham & Women\u2019s Hospital Boards Course.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This is a study using de-identified data. The Case Western Reserve University\/University Hospitals Institutional Review Board has confirmed that no ethical approval is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}